115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
    Review

    Perissinotti, A. J.; Bishop, M. R.; Bubalo, J.; Geyer, M. B.; Goodrich, A.; Howard, S. C.; Kula, J.; Mandayam, S.; Cairo, M. S.; Pui, C. H.
    Cancer Treatment Reviews (2023)

    Fulltext@MSK | Save
  • SHP2 inhibition sensitizes diverse oncogene-addicted solid tumors to re-treatment with targeted therapy
    Journal Article

    Drilon, A.; Sharma, M. R.; Johnson, M. L.; Yap, T. A.; Gadgeel, S.; Nepert, D.; Feng, G.; Reddy, M. B.; Harney, A. S.; Elsayed, M.; more...
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer
    Journal Article

    Li, X.; Wang, Y.; Deng, S.; Zhu, G.; Wang, C.; Johnson, N. A.; Zhang, Z.; Tirado, C. R.; Xu, Y.; Metang, L. A.; more...
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • Chromophobe renal cell carcinoma
    Editorial

    Henske, E. P.; Cheng, L.; Hakimi, A. A.; Choueiri, T. K.; Braun, D. A.
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • Patterns of immune equilibrium and escape in indolent and progressing tumors
    Research Letter

    Pandey, A.; Linxweiler, M.; Kuo, F.; Marti, J. L.; Roman, B.; Ehdaie, B.; Vos, J. L.; Morris, L. G. T.
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: An E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE
    Guidelines

    Siriwardena, A. K.; Serrablo, A.; Fretland, Å. A.; Wigmore, S. J.; Ramia-Angel, J. M.; Malik, H. Z.; Stättner, S.; Søreide, K.; Zmora, O.; Meijerink, M.; more...
    British Journal of Surgery (2023)

    Fulltext@MSK | Save
  • Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Journal Article

    Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: Consensus recommendations from an expert panel
    Review

    Raje, N.; Anderson, K.; Einsele, H.; Efebera, Y.; Gay, F.; Hammond, S. P.; Lesokhin, A. M.; Lonial, S.; Ludwig, H.; Moreau, P.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
    Journal Article

    Sawalha, Y.; Goyal, S.; Switchenko, J. M.; Romancik, J. T.; Kamdar, M.; Greenwell, I. B.; Hess, B. T.; Isaac, K. M.; Portell, C. A.; Garcia, A. M.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
    Journal Article

    Wudhikarn, K.; Tomas, A. A.; Flynn, J. R.; Devlin, S. M.; Brower, J.; Bachanova, V.; Nastoupil, L. J.; McGuirk, J. P.; Maziarz, R. T.; Oluwole, O. O.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save